09.08.2013 - Amyris to get up to $60 mln in Temasek funding for biofuels
Amyris Inc., the biotechnology company part-owned by Total SA, will sell as much as $60 million in convertible notes to Temasek Holdings Pte. Temasek will buy $35 million of notes in an initial tranche and later may purchase an additional $25 million of notes, Emeryville, California-based Amyris said today in a statement. The first tranche is expected to close next month. The second may be issued at the company’s discretion within two years of the agreement, depending on meeting certain milestones at a Brazil production site...............................................Full Article: Source
Print